Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Association of tamoxifen use and reduced cardiovascular events among asian females with breast cancer.

Yang TL, Wu TC, Huang CC, Huang PH, Chung CM, Lin SJ, Chen JW, Chan WL, Chiang CH, Leu HB.

Circ J. 2014;78(1):135-40.

2.

Selective estrogen receptor modulators and cardiovascular events.

Kitagawa K.

Circ J. 2014;78(1):63-4. No abstract available.

3.

The association of tooth scaling and decreased cardiovascular disease: a nationwide population-based study.

Chen ZY, Chiang CH, Huang CC, Chung CM, Chan WL, Huang PH, Lin SJ, Chen JW, Leu HB.

Am J Med. 2012 Jun;125(6):568-75. doi: 10.1016/j.amjmed.2011.10.034.

PMID:
22483056
4.

Stroke risk and tamoxifen therapy for breast cancer.

Geiger AM, Fischberg GM, Chen W, Bernstein L.

J Natl Cancer Inst. 2004 Oct 20;96(20):1528-36.

5.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.

J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62.

6.

Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.

Ligibel JA, James O'Malley A, Fisher M, Daniel GW, Winer EP, Keating NL.

Breast Cancer Res Treat. 2012 Jan;131(2):589-97. doi: 10.1007/s10549-011-1754-1.

PMID:
21881937
7.

Tamoxifen Treatment and the Reduced Risk of Hyperlipidemia in Asian Patients With Breast Cancer: A Population-Based Cohort Study.

Lim YP, Lin CL, Lin YN, Ma WC, Hung DZ, Kao CH.

Clin Breast Cancer. 2015 Aug;15(4):294-300. doi: 10.1016/j.clbc.2015.03.005.

PMID:
25922283
8.

Statins, risk of diabetes, and implications on outcomes in the general population.

Wang KL, Liu CJ, Chao TF, Huang CM, Wu CH, Chen SJ, Chen TJ, Lin SJ, Chiang CE.

J Am Coll Cardiol. 2012 Oct 2;60(14):1231-8. doi: 10.1016/j.jacc.2012.05.019.

9.

The Association Between Insomnia and Increased Future Cardiovascular Events: A Nationwide Population-Based Study.

Hsu CY, Chen YT, Chen MH, Huang CC, Chiang CH, Huang PH, Chen JW, Chen TJ, Lin SJ, Leu HB, Chan WL.

Psychosom Med. 2015 Sep;77(7):743-51. doi: 10.1097/PSY.0000000000000199.

PMID:
26355726
10.

Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.

McCaskill-Stevens W, Wilson J, Bryant J, Mamounas E, Garvey L, James J, Cronin W, Wickerham DL.

J Natl Cancer Inst. 2004 Dec 1;96(23):1762-9. Erratum in: J Natl Cancer Inst. 2005 Jan 5;97(1):71.

11.
12.

Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer.

Hackshaw A, Roughton M, Forsyth S, Monson K, Reczko K, Sainsbury R, Baum M.

J Clin Oncol. 2011 May 1;29(13):1657-63. doi: 10.1200/JCO.2010.32.2933.

PMID:
21422412
13.

Increased risk of acute myocardial infarction and stroke during hemorrhagic fever with renal syndrome: a self-controlled case series study.

Connolly-Andersen AM, Hammargren E, Whitaker H, Eliasson M, Holmgren L, Klingström J, Ahlm C.

Circulation. 2014 Mar 25;129(12):1295-302. doi: 10.1161/CIRCULATIONAHA.113.001870.

14.
16.

Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: a Taiwanese population-based longitudinal follow-up study.

Lai YT, Dai YS, Yen MF, Chen LS, Chen HH, Cooper RG, Pan SL.

Br J Dermatol. 2013 May;168(5):1054-9. doi: 10.1111/bjd.12245.

PMID:
23330740
17.

Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.

Ye X, Qian C, Liu J, St Peter WL.

Pharmacotherapy. 2013 Oct;33(10):1062-70. doi: 10.1002/phar.1317.

18.

Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE.

J Natl Cancer Inst. 2007 Mar 7;99(5):365-75.

19.

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.

Fisher B, Dignam J, Bryant J, DeCillis A, Wickerham DL, Wolmark N, Costantino J, Redmond C, Fisher ER, Bowman DM, Deschênes L, Dimitrov NV, Margolese RG, Robidoux A, Shibata H, Terz J, Paterson AH, Feldman MI, Farrar W, Evans J, Lickley HL.

J Natl Cancer Inst. 1996 Nov 6;88(21):1529-42.

20.

NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.

Kohli P, Steg PG, Cannon CP, Smith SC Jr, Eagle KA, Ohman EM, Alberts MJ, Hoffman E, Guo J, Simon T, Sorbets E, Goto S, Bhatt DL; REACH Registry Investigators..

Am J Med. 2014 Jan;127(1):53-60.e1. doi: 10.1016/j.amjmed.2013.08.017.

PMID:
24280110
Items per page

Supplemental Content

Support Center